OTCMKTS:SEOVF Sernova Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Sernova Corp. Please log in to your account or sign up in order to add this asset to your watchlist. $0.92 +0.02 (+1.76%) (As of 06/27/2022 12:00 AM ET) Add Compare Share Today's Range$0.87▼$0.9350-Day Range$0.78▼$1.2352-Week Range$0.73▼$1.76Volume30,016 shsAverage Volume41,203 shsMarket Capitalization$252.42 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort Interest View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive SEOVF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sernova and its competitors with MarketBeat's FREE daily newsletter. Email Address SEOVF Stock Forecast (MarketRank)Overall MarketRank™0.96 out of 5 starsAnalyst Opinion: 0.0Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 - 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Sernova. Previous Next 4.8 Community Rank Outperform VotesSernova has received 52 “outperform” votes. (Add your “outperform” vote.)Underperform VotesSernova has received 21 “underperform” votes. (Add your “underperform” vote.)Community SentimentSernova has received 71.23% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Sernova and other stocks. Vote “Outperform” if you believe SEOVF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SEOVF will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldSernova does not currently pay a dividend.Dividend GrowthSernova does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Sernova insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 0.01% of the stock of Sernova is held by institutions. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Sernova is -18.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Sernova is -18.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSernova has a P/B Ratio of 10.18. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Sernova (OTCMKTS:SEOVF)Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and/or hormones for the long-term treatment of various serious chronic diseases, such as diabetes, hemophilia, and thyroid disease. Sernova Corp. has a research collaboration with AgeX Therapeutics, Inc. to generate immune-protected therapeutic cells; and a research agreement with the University of Miami to advance the development of Cell Pouch cell therapy platform. The company was incorporated in 1998 and is headquartered in London, Canada.Read More SEOVF Stock News HeadlinesJune 7, 2022 | apnews.comSernova Announces Positive Updated Phase 1/2 Clinical Data on Cell Pouch System™ at American Diabetes Association 82nd Scientific Sessions 2022May 17, 2022 | seekingalpha.comEvotec teams up with Sernova to develop diabetes therapy, commits €20M equity investmentMay 17, 2022 | finance.yahoo.comSernova and Evotec Enter into an Exclusive Global Strategic Partnership for iPSC-Based Beta Cell Replacement Therapy to Develop and Commercialize a ‘Functional Cure’ for DiabetesJanuary 5, 2022 | uk.finance.yahoo.comSernova to Announce New Interim Results of its Type 1 Diabetes Clinical Trial During the 40th Annual J.P. Morgan Healthcare ConferenceJune 29, 2021 | finance.yahoo.comHere's Why We're Not At All Concerned With Sernova's (CVE:SVA) Cash Burn SituationFebruary 5, 2021 | finance.yahoo.comBTV News Alert Video: Sernova Corp. - A Functional Cure for Type I DiabetesFebruary 3, 2021 | benzinga.comSernova Corp. Announces C$10 Million Bought Deal Offering of UnitsJanuary 21, 2021 | theglobeandmail.comInvestors flock to Canadian device maker Sernova hoping to transform how diabetes is treatedJanuary 15, 2021 | finance.yahoo.comIIROC Trading Resumption - SVAAugust 28, 2020 | finance.yahoo.comBill Ackman Is Back in the Spotlight. Here’s an Overlooked Way to Invest in His Success.August 17, 2020 | ca.finance.yahoo.comSernova Corp. (SEOVF)June 8, 2020 | seekingalpha.comSernova to acquire cellular local immune protection technologyMay 22, 2020 | finance.yahoo.comDoes The Sernova Corp. (CVE:SVA) Share Price Tend To Follow The Market?See More Headlines Industry, Sector and Symbol Stock ExchangeOTCMKTS Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:SEOVF CUSIPN/A CIK1491434 Webwww.sernova.com Phone(519) 858-5184Fax519-858-5184EmployeesN/AYear FoundedN/ACompany Calendar Today6/28/2022Fiscal Year End10/31/2022Profitability EPS (Most Recent Fiscal Year)($0.05) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-5.54 million Net MarginsN/A Pretax MarginN/A Return on Equity-36.34% Return on Assets-34.73% Debt Debt-to-Equity Ratio0.01 Current Ratio19.19 Quick Ratio19.19 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.09 per share Price / Book10.18Miscellaneous Outstanding Shares275,630,000Free FloatN/AMarket Cap$252.42 million OptionableNot Optionable Beta1.17 Sernova Frequently Asked Questions How has Sernova's stock price performed in 2022? Sernova's stock was trading at $1.45 at the beginning of 2022. Since then, SEOVF stock has decreased by 36.8% and is now trading at $0.9158. View the best growth stocks for 2022 here. Who are Sernova's key executives? Sernova's management team includes the following people: Mr. Frank A. Holler MBA, Exec. Chairman (Age 65, Pay $51.51k)Dr. Philip M. Toleikis B.A., M.Sc., Ph.D., Pres, CEO & DirectorMr. David Swetlow C.A, C.A., CPA, Chief Financial OfficerMr. Douglas Maret, Chief Science OfficerMr. Christopher Barnes, VP of Investor Relations Who are some of Sernova's key competitors? Some companies that are related to Sernova include Chinook Therapeutics (KDNY), Procaps Group (PROC), Avid Bioservices (CDMO), BELLUS Health (BLU), MannKind (MNKD), ImmunoGen (IMGN), Aclaris Therapeutics (ACRS), Crinetics Pharmaceuticals (CRNX), Veru (VERU), Merus (MRUS), I-Mab (IMAB), Enanta Pharmaceuticals (ENTA), Deciphera Pharmaceuticals (DCPH), uniQure (QURE) and Rocket Pharmaceuticals (RCKT). View all of SEOVF's competitors. What is Sernova's stock symbol? Sernova trades on the OTCMKTS under the ticker symbol "SEOVF." How do I buy shares of Sernova? Shares of SEOVF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Sernova's stock price today? One share of SEOVF stock can currently be purchased for approximately $0.92. How much money does Sernova make? Sernova (OTCMKTS:SEOVF) has a market capitalization of $252.42 million. The company earns $-5.54 million in net income (profit) each year or ($0.05) on an earnings per share basis. How can I contact Sernova? Sernova's mailing address is 700 COLLIP CIRCLE SUITE 114, LONDON A6, N6G 4X8. The official website for Sernova is www.sernova.com. The company can be reached via phone at (519) 858-5184, via email at [email protected], or via fax at 519-858-5184. This page (OTCMKTS:SEOVF) was last updated on 6/28/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here